Nippon India Pharma Fund - Direct (G) vs SBI Overnight Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs SBI Overnight Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

7.4%

stock2

SBI Overnight Fund - Direct (G)

5.29%

Loading chart...

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Citi Bank HDFC Bank Ltd. Stock Holding Corporation of India

Computer Age Management Services Pvt. Ltd Computronics Financial Services India Ltd Datamatics Financial Software Services Ltd

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

Low Risk

5000

34033.24

0.16

4452.7234

January 1, 2013

0

14.01 %

19.35 %

7.4 %

5.62 %

6.11 %

5.29 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

R Arun

B. Com & post graduation in Finance.

He has over 6 years of work experience including 4 years of experience in mutual fund Industry as Credit Research Analyst. He has been associated with SBI Funds Management Pvt.Ltd. from March 2009 onwards as Credit Analyst. Prior to joining SBI Funds Management, he worked with ING Investment Management, Deutsche Bank Operations India & Crisil as Credit Analyst.

Ranjana Gupta

B.Com

Ranjana Gupta Joined SBIFMPL in 2008 as Fixed Income Dealer and has over 21 years of experience on capital market. Prior to joining SBIFMPL, Ranjana was heading the broking activities at Twentyfirst Century Shares and Securities Ltd from May 1995 to February 2008. She started her career as a dealer in 1995 with OTCEI (Over the Counter Exchange of India). Ranjana is a Commerce graduate from Mumbai University.

Get your FAQs right